07:41 AM EDT, 08/05/2025 (MT Newswires) -- Madrigal Pharmaceuticals ( MDGL ) reported a Q2 net loss Tuesday of $1.90 per share, narrowing from a loss of $7.10 a year earlier.

Analysts polled by FactSet expected a loss of $3.55 per share.

Total revenue for the quarter ended June 30 was $212.8 million, compared with $14.6 million a year earlier.

Analysts surveyed by FactSet expected $162.0 million.

Shares of the company were up 15.3% in recent premarket activity.